4//SEC Filing
Disbrow Joshua R. 4
Accession 0001437749-25-030642
CIK 0001385818other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:11 PM ET
Size
17.6 KB
Accession
0001437749-25-030642
Insider Transaction Report
Form 4
Disbrow Joshua R.
Chief Executive Officer
Transactions
- Award
Common Stock
2025-10-03+22,500→ 207,203 total - Award
Common Stock
2025-10-03+31,446→ 184,703 total
Footnotes (2)
- [F1]The reporting person was granted fully vested restricted stock in lieu of cash in satisfaction of their annual bonus.
- [F2]Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027.
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
Related Parties
1- filerCIK 0001566240
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:11 PM ET
- Size
- 17.6 KB